Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2022

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/23/2026

1. SPY
2. PATH
3. KBH
4. USO
5. AZO
6. QQQ
7. META
8. ORCL
9. RCL
10. ONON

Go back to Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2022
(NASDAQ: GMAB) Delayed: 34.75 -0.47 (1.33%)
Previous Close $35.22    52 Week High $ 
Open $35.39    52 Week Low $ 
Day High $35.66    P/E N/A 
Day Low $34.61    EPS $ 
Volume 2,509,747